Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19
Temístocles Díaz, Barry Trachtenberg, Samuel JK Abraham, Rao Kosagisharaf, Armando A. Durant-Archibold
Abstract
OPINION article Front. Cardiovasc. Med., 30 November 2020Sec. Cardiovascular Epidemiology and Prevention Volume 7 - 2020 | https://doi.org/10.3389/fcvm.2020.562708
Topics & Concepts
AspirinCoronavirus disease 2019 (COVID-19)MedicineEpidemiology2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CardiologyInternal medicineIntensive care medicineDiseasePathologyOutbreakInfectious disease (medical specialty)COVID-19 Clinical Research StudiesAdipokines, Inflammation, and Metabolic DiseasesInflammasome and immune disorders